Neuronetics: Jorey Chernett reports about 2.71% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Neuronetics, Inc. (STIM) reported that Jorey Chernett beneficially owned 2,104,026 shares, approximately 2.71% of the company, as of November 13, 2026. The amendment is his final Schedule 13D amendment and an exit filing because he no longer beneficially owned more than 5%.
Chernett reported sole voting and dispositive power over those shares. He said they were purchased with personal funds for an aggregate purchase price of approximately $4,114,294, calculated on an average-cost basis. Neuronetics had 77,728,311 shares outstanding as of October 28, 2026.
Key Figures
Key Terms
beneficially owned technical
sole dispositive power technical
average-cost basis financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why is Jorey Chernett's STIM ownership filing an exit filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.